I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Willekes, Merel
8
results:
Search for persons
X
Format
Online (8)
Mediatypes
Articles (Online) (2)
OpenAccess-fulltext (6)
Sorted by: Relevance
Sorted by: Year
?
1
MEK inhibition is a promising therapeutic strategy for MLL-..:
Kerstjens, Mark
;
Driessen, Emma M.C.
;
Willekes, Merel
...
Oncotarget. 8 (2016) 9 - p. 14835-14846 , 2016
Link:
https://doi.org/10.18632..
?
2
MLL fusion-driven activation ofCDK6potentiates proliferatio..:
Van der Linden, Marieke
;
Willekes, Merel
;
van Roon, Eddy
...
Cell Cycle. 13 (2014) 5 - p. 834-844 , 2014
Link:
https://doi.org/10.4161/..
?
3
MEK inhibition is a promising therapeutic strategy for MLL-..:
Kerstjens, Mark
;
Driessen, Emma
;
Willekes, Merel
...
Kerstjens , M , Driessen , E , Willekes , M , Mimoso Pinhancos , S , Schneider , P , Pieters , R & Stam , R 2017 , ' MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations ' , Oncotarget , vol. 8 , no. 9 , pp. 14835-14846 . https://doi.org/10.18632/oncotarget.11730. , 2017
Link:
https://pure.eur.nl/en/p..
?
4
Clinical and molecular genetic characterization of wild-typ..:
van der Linden, Marieke H
;
Boer, Judith M
;
Schneider, Pauline
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815736/. , 2016
Link:
http://www.ncbi.nlm.nih...
?
5
MLL fusion-driven activation of CDK6 potentiates proliferat..:
van der Linden, Marieke H
;
Willekes, Merel
;
van Roon, Eddy
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014
Link:
http://www.ncbi.nlm.nih...
?
6
MEK inhibition is a promising therapeutic strategy for MLL-..:
Kerstjens, M.J.B. (Mark)
;
Driessen, E.M.C. (Emma)
;
Willekes, M. (Merel)
...
http://repub.eur.nl/pub/98211. , 2017
Link:
http://repub.eur.nl/pub/..
?
7
Clinical and molecular genetic characterization of wild-typ..:
Linden, M.H. (Marieke) van der
;
Boer, J.M. (Judith)
;
Schneider, P. (Petra)
...
info:eu-repo/grantAgreement/EC/FP7/261474. , 2016
Link:
http://repub.eur.nl/pub/..
?
8
MLL fusion-driven activation of CDK6 potentiates proliferat..:
Linden, M.H. (Marieke) van der
;
Willekes, M. (Merel)
;
Roon, E. (Eddy) van
...
http://repub.eur.nl/pub/70252. , 2014
Link:
http://repub.eur.nl/pub/..
1-8
